Clinical trial BHS-TC11-01
A Phase II study to assess the safety and the efficacy of extracorporeal photopheresis using the Theraflex ECPTM (Macropharma) for patients with refractory chronic GVHD
| Cancers | |
|---|---|
| Organ | NA |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional without experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Oui |
| Sponsor | BHS |
| BECT Identifier | B079201318627 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03083574 |
| Inclusion criteria | chronic GVHD - already been treated with first-line systemic therapy for at least 1 month - refractoriness or contraindication/intolerance to current therapy |
| Last update |